David Lin, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A127907 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$21,629
Medicare paid this office $21,629 for 197 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 65 | $5,988 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,991 | $148 |
| Short return visit (20+ min) | 41 | $1,720 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $939 | $27 |
| Biopsy of large bowel using a flexible endoscope | 12 | $506 | $42 |
See all 6 services
| Return visit (30+ min) | 65 | $5,988 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,991 | $148 |
| Short return visit (20+ min) | 41 | $1,720 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $939 | $27 |
| Biopsy of large bowel using a flexible endoscope | 12 | $506 | $42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 26 | $113 | $4 |
Procedures Medicare counted
| Colonoscopy | 33 | More than 55% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 29 | More than 55% of doctors who do this |
Who their Medicare patients are
197 Original Medicare patients in 2024. Average age 71 · Under 65 15% · 85 and older 6% · Women 56% · Also on Medicaid 83% · Health risk score 1.90. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 48% · Depression 26% · Coronary heart disease 24% · Chronic kidney disease 23% · COPD 21% · Heart failure 16% · Atrial fibrillation 16% · Cancer 13% · Stroke 13% · Dementia 9%.
The office billed $261,043, Medicare allowed $31,612 and paid $21,629; for 317 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 197 | 317 | 71 | 1.90 | $261,043 | $21,629 |
| 2023 | 257 | 424 | 70 | 1.69 | $371,198 | $33,396 |
| 2022 | 222 | 382 | 70 | 1.58 | $249,987 | $27,746 |
| 2021 | 258 | 438 | 70 | 1.81 | $245,385 | $28,701 |
| 2020 | 262 | 477 | 69 | 2.02 | $323,831 | $30,804 |
| 2019 | 274 | 590 | 68 | 1.91 | $503,534 | $45,588 |
| 2018 | 91 | 174 | 68 | 1.94 | $128,765 | $15,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 100 | $8,958 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,907 | $158 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $3,272 | $172 |
| Short return visit (20+ min) | 48 | $2,963 | $51 |
| New patient visit (45+ min) | 24 | $2,567 | $107 |
| Long return visit (40+ min) | 13 | $1,636 | $109 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,594 | $106 |
| Biopsy of large bowel using a flexible endoscope | 13 | $1,038 | $80 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 46 | $223 | $5 |
2022: 8 services
| Return visit (30+ min) | 56 | $6,167 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,597 | $219 |
| Short return visit (20+ min) | 36 | $2,113 | $59 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,350 | $112 |
| Telephone medical discussion with physician, 5-10 minutes | 48 | $1,078 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $943 | $79 |
| Short return visit | 32 | $834 | $25 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 39 | $212 | $5 |
2021: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $5,457 | $227 |
| Telephone medical discussion with physician, 5-10 minutes | 121 | $5,126 | $32 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $4,565 | $97 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,918 | $208 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,809 | $95 |
| Biopsy of large bowel using a flexible endoscope | 11 | $864 | $79 |
| Short return visit (20+ min) | 13 | $848 | $61 |
| Study of esophagus to assess movement | 16 | $751 | $47 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 16 | $615 | $38 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 39 | $195 | $5 |
2020: 10 services
| Telephone medical discussion with physician, 21-30 minutes | 63 | $5,047 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,967 | $216 |
| Telephone medical discussion with physician, 11-20 minutes | 74 | $3,703 | $44 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,175 | $187 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,483 | $92 |
| Return visit (30+ min) | 44 | $1,799 | $39 |
| Biopsy of large bowel using a flexible endoscope | 22 | $1,576 | $72 |
| Telephone medical discussion with physician, 5-10 minutes | 41 | $1,028 | $22 |
| Study of esophagus to assess movement | 11 | $688 | $63 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 53 | $251 | $5 |
2019: 12 services
| Return visit (30+ min) | 97 | $7,567 | $65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $7,450 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,150 | $181 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,968 | $97 |
| Biopsy of large bowel using a flexible endoscope | 45 | $3,777 | $82 |
| New patient visit (45+ min) | 46 | $3,746 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,882 | $93 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,303 | $93 |
| Short return visit | 24 | $592 | $23 |
| Short return visit (20+ min) | 12 | $549 | $46 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 92 | $470 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $425 | $25 |
2018: 8 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,811 | $234 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,365 | $182 |
| New patient visit (45+ min) | 16 | $1,844 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,779 | $94 |
| Return visit (30+ min) | 21 | $1,550 | $70 |
| Biopsy of large bowel using a flexible endoscope | 14 | $1,406 | $100 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,027 | $93 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 33 | $154 | $5 |
Medicaid work
$27,304 in 2024
Medicaid paid $27,304 for 3,629 billed services this clinician did in 2024, up to 108 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 420 | $7,397 |
| Service | 173 | $5,885 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 234 | $5,095 |
| COLONOSCOPY AND BIOPSY | 91 | $4,013 |
| COLONOSCOPY W/LESION REMOVAL | 25 | $1,434 |
| TISSUE EXAM BY PATHOLOGIST | 212 | $1,177 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 33 | $910 |
| Short return visit (20+ min) | 75 | $621 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 170 | $318 |
| Esophagus, gastroesophageal reflux test; with mucosal attached telemetry pH electrode placement, recording, analysis and interpretation | 13 | $284 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 118 | $153 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 18 | $18 |
| 2024 | 3,629 | 22 | 108 | $27,304 |
| 2023 | 1,435 | 15 | 58 | $9,492 |
| 2022 | 779 | 7 | 34 | $7,814 |
| 2021 | 639 | 8 | 35 | $8,364 |
| 2020 | 460 | 7 | 48 | $8,749 |
| 2019 | 981 | 13 | 90 | $12,084 |
| 2018 | 399 | 7 | 29 | $6,005 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 462 | $2,832 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 164 | $2,814 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 54 | $1,431 |
| TISSUE EXAM BY PATHOLOGIST | 138 | $796 |
| Short return visit (20+ min) | 149 | $582 |
| Service | 61 | $330 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 148 | $309 |
| Long return visit (40+ min) | 15 | $234 |
| COLONOSCOPY AND BIOPSY | 15 | $119 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 27 | $28 |
| New patient visit (45+ min) | 12 | $15 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 57 | $0 |
2022
| Return visit (30+ min) | 304 | $2,828 |
| Short return visit (20+ min) | 167 | $1,389 |
| Upper gastrointestinal endoscopy with biopsy | 15 | $1,286 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 49 | $1,279 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 139 | $471 |
| Short return visit | 93 | $443 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $119 |
2021
| Return visit (30+ min) | 228 | $3,068 |
| Short return visit (20+ min) | 244 | $2,011 |
| COLONOSCOPY W/LESION REMOVAL | 13 | $1,081 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 14 | $828 |
| COLONOSCOPY AND BIOPSY | 13 | $713 |
| New patient visit (30+ min) | 12 | $290 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 14 | $237 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 101 | $136 |
2020
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 199 | $3,049 |
| COLONOSCOPY AND BIOPSY | 36 | $2,082 |
| Upper gastrointestinal endoscopy with biopsy | 25 | $1,668 |
| Return visit (30+ min) | 95 | $820 |
| New patient visit (45+ min) | 54 | $692 |
| Short return visit | 31 | $291 |
| Short return visit (20+ min) | 20 | $148 |
2019
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 42 | $2,338 |
| Return visit (30+ min) | 333 | $2,303 |
| Upper gastrointestinal endoscopy with biopsy | 47 | $1,789 |
| COLONOSCOPY W/LESION REMOVAL | 12 | $1,275 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 142 | $1,225 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 125 | $1,022 |
| COLONOSCOPY AND BIOPSY | 57 | $785 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 51 | $594 |
| Short return visit | 68 | $298 |
| New patient visit (45+ min) | 60 | $213 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 18 | $141 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 12 | $70 |
2018
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 28 | $1,242 |
| TISSUE EXAM BY PATHOLOGIST | 58 | $1,141 |
| Service | 60 | $1,126 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 51 | $1,033 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 78 | $709 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 72 | $706 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 52 | $50 |
Drugs they prescribed that Part D paid
$98,274
Pharmacies billed $98,274 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 205) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
146 generic and 59 brand-name prescriptions · $98,274 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 20 | $27,897 | $1,395 |
| Entecavir | 20 | $6,043 | $302 |
| Dexlansoprazole Dr | 19 | $3,671 | $193 |
| Omeprazole | 23 | $333 | $14 |
| Peg-3350 and Electrolytes | 13 | $233 | $18 |
See all 6 drugs
| Vemlidy | 20 | $27,897 | $1,395 |
| Entecavir | 20 | $6,043 | $302 |
| Dexlansoprazole Dr | 19 | $3,671 | $193 |
| Omeprazole | 23 | $333 | $14 |
| Peg-3350 and Electrolytes | 13 | $233 | $18 |
| Carvedilol | 20 | $35 | $2 |
Year by year
| 2024 | 205 | 60 | 0% (0) | 29% | $98,274 |
| 2023 | 234 | 77 | 0% (0) | 39% | $128,049 |
| 2022 | 199 | 60 | 0% (0) | 37% | $82,629 |
| 2021 | 247 | 79 | 0% (0) | 41% | $109,043 |
| 2020 | 318 | 117 | None | 30% | $52,107 |
| 2019 | 191 | 99 | None | 44% | $60,367 |
| 2018 | 42 | 30 | None | 45% | $1,354 |
| 2017 | 19 | None | None | 0% | $3,960 |
| 2014 | 17 | None | None | 0% | $1,022 |
| 2013 | 11 | None | None | None | $1,471 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Creon | 11 | $28,167 | $2,561 |
| Vemlidy | 13 | $20,870 | $1,605 |
| Entecavir | 20 | $9,442 | $472 |
| Dexilant | 11 | $2,805 | $255 |
| Peg-3350 and Electrolytes | 26 | $644 | $25 |
| Gavilyte-G | 16 | $346 | $22 |
| Pantoprazole | 12 | $178 | $15 |
| Omeprazole | 14 | $153 | $11 |
| Carvedilol | 12 | $28 | $2 |
2022: 7 drugs
| Creon | 12 | $31,045 | $2,587 |
| Linzess | 18 | $12,921 | $718 |
| Entecavir | 18 | $7,456 | $414 |
| Dexilant | 11 | $3,649 | $332 |
| Omeprazole | 26 | $415 | $16 |
| Pantoprazole | 16 | $365 | $23 |
| Buspirone | 12 | $205 | $17 |
2021: 11 drugs
| Creon | 22 | $38,998 | $1,773 |
| Vemlidy | 13 | $17,687 | $1,361 |
| Linzess | 20 | $14,100 | $705 |
| Dexilant | 12 | $3,923 | $327 |
| Entecavir | 19 | $2,857 | $150 |
| Esomeprazole Magnesium | 11 | $2,345 | $213 |
| Suprep | 11 | $1,221 | $111 |
| Omeprazole | 34 | $414 | $12 |
| Pantoprazole | 27 | $390 | $14 |
| Peg-3350 and Electrolytes | 15 | $212 | $14 |
| Buspirone | 12 | $155 | $13 |
2020: 10 drugs
| Creon | 13 | $14,915 | $1,147 |
| Linzess | 14 | $8,474 | $605 |
| Tenofovir Disoproxil | 25 | $5,252 | $210 |
| Esomeprazole Magnesium | 17 | $3,661 | $215 |
| Suprep | 16 | $2,390 | $149 |
| Entecavir | 22 | $2,285 | $104 |
| Cholestyramine Light | 14 | $979 | $70 |
| Peg-3350 and Electrolytes | 31 | $407 | $13 |
| Omeprazole | 41 | $387 | $9 |
| Pantoprazole | 33 | $276 | $8 |
2019: 5 drugs
| Peg-3350 and Electrolytes | 54 | $713 | $13 |
| Tenofovir Disoproxil | 11 | $609 | $55 |
| Gavilyte-G | 14 | $266 | $19 |
| Omeprazole | 16 | $183 | $11 |
| Pantoprazole | 14 | $171 | $12 |
2018: 1 drug
| Peg-3350 and Electrolytes | 18 | $253 | $14 |
Money from drug and device companies
$56 in 2023
| 2023 | 2 | 2 | None | $56 |
| 2021 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Erbe USA | Erbe Vio3 | $31 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $25 | 1 payment
|
See all 2 published payments
| Intercept Pharmaceuticals | Meals · 2023-09-20 | Ocaliva | $25 |
| Erbe USA | Meals · 2023-06-29 | Erbe Vio3 | $31 |
See earlier years (2021)
2021: $18
| Takeda Pharmaceuticals U.S.A. | Entyvio | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386910560
- Licence
- CA A127907California A127907: Current · expires 2027-04-30
- Trained
- Northwestern University Feinberg Medical School, 2012
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2012-04-01
- NPI last updated
- 2020-03-27
- NPI record certified
- 2020-03-27
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.